World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

Role of Fibrocytes in Renal Fibrosis

    https://doi.org/10.1142/9789812706690_0009Cited by:0 (Source: Crossref)
    Abstract:

    Fibrosis is a characteristic pathological feature of progressive organ diseases, resulting in organ failure. Renal fibrosis is a progressive and potentially lethal disease caused by diverse clinical entities. The degree of renal fibrosis well correlates with the prognosis of renal diseases independent of their etiologies. Fibrocytes are peculiar circulating cells that share markers of leukocytes as well as mesenchymal cells. A considerable number of fibrocytes dual positive for CD45 and type I collagen or CD34 and type I collagen infiltrated the interstitium along with progression of fibrosis in an experimental murine renal fibrosis model. Most fibrocytes in the kidneys were positive for CCR7. In addition, a ligand for CCR7, secondary lymphoid tissue chemokine (SLC/CCL21) co-localized with high endothelial venule-like vessels in fibrotic kidneys. CCL21/CCR7 blockade reduced the number of infiltrating fibrocytes as well as the extent of renal fibrosis, which was confirmed by a decrease in renal transcripts of pro a1 chain of type I collagen and transforming growth factor-β1. These findings suggest that fibrocytes contribute to the progressive renal fibrosis dependent on CCL21/CCR7 signaling.